Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009:101:81-121.
doi: 10.1016/S0065-2776(08)01003-1.

Biology of the eosinophil

Affiliations
Review

Biology of the eosinophil

Carine Blanchard et al. Adv Immunol. 2009.

Abstract

In this review, we aim to put in perspective the biology of a multifunctional leukocyte, the eosinophil, by placing it in the context of innate and adaptive immune responses. Eosinophils have a unique contribution in initiating inflammatory and adaptive responses, due to their bidirectional interactions with dendritic cells and T cells, as well as their large panel of secreted cytokines and soluble mediators. The mechanisms and consequences of eosinophil responses in experimental inflammatory models and human diseases are discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1. From the hematopoietic stem cell to the mature eosinophil
Eosinophils develop in the bone marrow. Transcription factor (such as Δdbl-GATA-1) and cytokines (such as IL-5, IL-3 and GM-CSF) are essential for their differentiation from an hematopoietic stem cell into the mature eosinophil. Once mature, IL-5 controls the eosinophil migration from the bone marrow to the blood. At baseline, eosinophils localize in the thymus, GI tract, uterus and mammary gland. Eosinophils are able to express and to secrete, at baseline or upon stimulation, a large variety of mediators (cytokines, granule proteins, lipid mediators). Eosinophils are putative antigen presenting cells and play a role in mast cell activation, T cell communication and function.
Figure 2
Figure 2. Eosinophil trafficking
Once mature in the bone marrow, IL-5 controls the migration of eosinophils into the blood. At baseline, eotaxin-1 drives eosinophils in the thymus, uterus, mammary gland and gastrointestinal tract. Eosinophils express adhesion molecules (integrins) that allow attachment to the endothelial surface (VCAM-1, MadCAM-1, ICAM-1). Tissue chemokine expression allows the formation of a gradient chemotactic that guide the eosinophils in the tissue. In Th2 diseases, Th2 cytokines increase chemokine expression. In the asthmatic lung, eotaxin-1, 2 and -3 are increased and/or involved in chemotaxis of eosinophils, as well as other molecules such as LTB4. In the gastrointestinal tract eotaxin-3 is a key player in the eosinophilia observed in eosinophilic esophagitis while eotaxin-1 has been shown to be involved in the lower gastrointestinal eosinophilic diseases.
Figure 3
Figure 3. Eosinophil function
Eosinophils are believed to have a beneficial role in helminthic infection while no direct evidence was provided in the eosinophil depleted mice. Ribonuclease in granules display anti viral property on RNA virus such as RSV. Eosinophils are able to bind to fungal wall via their β2 integrin chain. Finally, DNA traps possess antibacterial activities. Eosinophils are involved in the pathological features of several diseases. In asthma, using eosinophil depleted mice (Δdbl-GATA-1 and PHIL) eosinophils have been shown involved in AHR, mucus production, TH2 cytokine production and collagen deposition. The role of eosinophils in EGID and HES might lead to tissue damage but needs to be better studied.

References

    1. Aceves SS, Dohil R, Newbury RO, Bastian JF. J Allergy Clin Immunol. 2005;116:705. - PubMed
    1. Ackerman SJ, Gleich GJ, Loegering DA, Richardson BA, Butterworth AE. Am J Trop Med Hyg. 1985;34:735. - PubMed
    1. Adamko DJ, Yost BL, Gleich GJ, Fryer AD, Jacoby DB. J Exp Med. 1999;190:1465. - PMC - PubMed
    1. Agosti JM, Altman LC, Ayars GH, Loegering DA, Gleich GJ, Klebanoff SJ. J Allergy Clin Immunol. 1987;79:496. - PubMed
    1. Ajuebor MN, Hogaboam CM, Kunkel SL, Proudfoot AE, Wallace JL. J Immunol. 2001;166:552. - PubMed

Publication types

MeSH terms